Identification of novel hypermethylated genes and demethylating effect of vincristine in colorectal cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Moon, Ji Wook | - |
dc.contributor.author | Lee, Soo Kyung | - |
dc.contributor.author | Lee, Jung Ok | - |
dc.contributor.author | Kim, Naml | - |
dc.contributor.author | Lee, Yong Woo | - |
dc.contributor.author | Kim, Su Jin | - |
dc.contributor.author | Kang, Ho Jin | - |
dc.contributor.author | Kim, Jin | - |
dc.contributor.author | Kim, Hyeon Soo | - |
dc.contributor.author | Park, Sun-Hwa | - |
dc.date.accessioned | 2021-09-05T12:24:42Z | - |
dc.date.available | 2021-09-05T12:24:42Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2014-01-06 | - |
dc.identifier.issn | 1756-9966 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/99553 | - |
dc.description.abstract | Background: Colorectal cancer (CRC) arises as a consequence of genetic events such as gene mutation and epigenetic alteration. The aim of this study was to identify new hypermethylated candidate genes and methylation-based therapeutic targets using vincristine in CRC. Methods: We analyzed the methylation status of 27,578 CpG sites spanning more than 14,000 genes in CRC tissues compared with adjacent normal tissues and normal colon tissues using Illumina bead chip array. Twenty-one hypermethylated genes and 18 CpG island methylator phenotype markers were selected as candidate genes. The methylation status of 39 genes was validated by quantitative methylation-specific polymerase chain reaction in CRC tissues, adjacent normal tissues, normal colon cells, and three CRC cell lines. Of these, 29 hypermethylated candidate genes were investigated using the demethylating effects of 5-aza-2'-deoxycytidine (5-aza-dC) and vincristine in CRC cells. Results: Thirty-two out of 39 genes were hypermethylated in CRC tissues compared with adjacent normal tissues. Vincristine induced demethylation of methylated genes in CRC cells to the same extent as 5-aza-dC. The mRNA expression of AKR1B1, CHST10, ELOVL4, FLI1, SOX5, STK33, and ZNF304 was restored by treatment with 5-aza-dC and vincristine. Conclusion: These results suggest that these novel hypermethylated genes AKR1B1, CHST10, ELOVL4, SOX5, STK33, and ZNF304 may be potential methylation biomarkers and therapeutic targets of vincristine in CRC. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | BMC | - |
dc.subject | ISLAND METHYLATOR PHENOTYPE | - |
dc.subject | TUMOR-SUPPRESSOR GENES | - |
dc.subject | DNA METHYLATION | - |
dc.subject | MICROSATELLITE INSTABILITY | - |
dc.subject | COMBINATION CHEMOTHERAPY | - |
dc.subject | BRAF MUTATION | - |
dc.subject | CYCLOPHOSPHAMIDE | - |
dc.subject | 5-AZACYTIDINE | - |
dc.subject | EPIGENETICS | - |
dc.subject | ADRIAMYCIN | - |
dc.title | Identification of novel hypermethylated genes and demethylating effect of vincristine in colorectal cancer | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Jin | - |
dc.contributor.affiliatedAuthor | Kim, Hyeon Soo | - |
dc.contributor.affiliatedAuthor | Park, Sun-Hwa | - |
dc.identifier.doi | 10.1186/1756-9966-33-4 | - |
dc.identifier.scopusid | 2-s2.0-84891551009 | - |
dc.identifier.wosid | 000331740700002 | - |
dc.identifier.bibliographicCitation | JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, v.33 | - |
dc.relation.isPartOf | JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH | - |
dc.citation.title | JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH | - |
dc.citation.volume | 33 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | ISLAND METHYLATOR PHENOTYPE | - |
dc.subject.keywordPlus | TUMOR-SUPPRESSOR GENES | - |
dc.subject.keywordPlus | DNA METHYLATION | - |
dc.subject.keywordPlus | MICROSATELLITE INSTABILITY | - |
dc.subject.keywordPlus | COMBINATION CHEMOTHERAPY | - |
dc.subject.keywordPlus | BRAF MUTATION | - |
dc.subject.keywordPlus | CYCLOPHOSPHAMIDE | - |
dc.subject.keywordPlus | 5-AZACYTIDINE | - |
dc.subject.keywordPlus | EPIGENETICS | - |
dc.subject.keywordPlus | ADRIAMYCIN | - |
dc.subject.keywordAuthor | Colorectal cancer | - |
dc.subject.keywordAuthor | Hypermethylated genes | - |
dc.subject.keywordAuthor | Therapeutic targets | - |
dc.subject.keywordAuthor | CIMP markers | - |
dc.subject.keywordAuthor | 5-aza-2&apos | - |
dc.subject.keywordAuthor | -deoxycytidine | - |
dc.subject.keywordAuthor | Vincristine | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.